Lv0
0 积分 2026-02-01 加入
CAR T-cell immunotherapy: a powerful weapon for fighting hematological B-cell malignancies
4个月前
已完结
Spectrum, pathobiology, mechanistic insights and diagnostic challenges of post-CAR T cell therapy lymphoproliferative disorders
4个月前
已完结
Efficacy and Safety Comparisons of Four Approved Chimeric Antigen Receptor T-Cell Therapies in Multiple Myeloma
5个月前
已完结
Rethinking mechanisms of neurotoxicity with BCMA directed therapy
5个月前
已完结
Prevention and management of adverse events during treatment with bispecific antibodies and CAR T cells in multiple myeloma: a consensus report of the European Myeloma Network
6个月前
已完结
International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple Myeloma
8个月前
已完结
Multiple myeloma
9个月前
已完结
皖公网安备34019202002308
